ES1323788U - Dietary supplement to support joint function - Google Patents
Dietary supplement to support joint functionInfo
- Publication number
- ES1323788U ES1323788U ES202431641U ES202431641U ES1323788U ES 1323788 U ES1323788 U ES 1323788U ES 202431641 U ES202431641 U ES 202431641U ES 202431641 U ES202431641 U ES 202431641U ES 1323788 U ES1323788 U ES 1323788U
- Authority
- ES
- Spain
- Prior art keywords
- joint function
- support joint
- omega
- dietary supplement
- msm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
DESCRIPCIÓN DESCRIPTION
Complemento alimenticio para apoyar la función articular Dietary supplement to support joint function
Sector Técnico Technical Sector
La presente invención se sitúa en el campo de la salud y la nutrición, más específicamente abarca la formulación y desarrollo de productos que proporcionan nutrientes esenciales y compuestos bioactivos para apoyar la función articular y mejorar la calidad de vida de los individuos. The present invention is situated in the field of health and nutrition, more specifically encompassing the formulation and development of products that provide essential nutrients and bioactive compounds to support joint function and improve the quality of life of individuals.
Estado de la Técnica State of the Art
Los complementos alimenticios destinados al apoyo de la función articular han ganado popularidad en las últimas décadas, particularmente en poblaciones envejecidas. En la actualidad, existen diversas formulaciones comerciales que incluyen ingredientes como el Metilsulfonilmetano (MSM), el Omega 3, la cúrcuma, el colágeno hidrolizado, la glucosamina y la condroitina, entre otros. Estos componentes se emplean por sus efectos beneficiosos sobre la función articular. Dietary supplements designed to support joint function have gained popularity in recent decades, particularly among aging populations. Currently, there are various commercial formulations that include ingredients such as methylsulfonylmethane (MSM), omega-3 fatty acids, turmeric, hydrolyzed collagen, glucosamine, and chondroitin, among others. These components are used for their beneficial effects on joint function.
Por su parte, el Omega 3 es un ácido graso poliinsaturado que ha demostrado tener efectos antiinflamatorios y cardioprotectores. Es particularmente efectivo en la modulación de la respuesta inmune, reduciendo la producción de mediadores inflamatorios como las prostaglandinas y los leucotrienos. En el ámbito de la salud articular, el Omega 3 contribuye a la preservación de la integridad del cartílago. Omega-3, a polyunsaturated fatty acid, has been shown to have anti-inflammatory and cardioprotective effects. It is particularly effective in modulating the immune response, reducing the production of inflammatory mediators such as prostaglandins and leukotrienes. In terms of joint health, Omega-3 contributes to preserving cartilage integrity.
En comparación con otros complementos existentes en el mercado, la presente invención se distingue por su formulación que combina MSM y un agente antiinflamatorio natural. In comparison with other supplements on the market, the present invention is distinguished by its formulation that combines MSM and a natural anti-inflammatory agent.
Explicación de la Invención Explanation of the Invention
La presente invención se refiere a un complemento alimenticio diseñado para ofrecer un soporte nutricional integral en el contexto de situaciones asociadas a trastornos articulares. La composición del complemento alimenticio se basa en una selección específica de ingredientes con características funcionales complementarias, cuya combinación ha sido desarrollada con el objetivo de favorecer el mantenimiento de las estructuras articulares en condiciones normales. The present invention relates to a food supplement designed to provide comprehensive nutritional support in the context of situations associated with joint disorders. The composition of the food supplement is based on a specific selection of ingredients with complementary functional characteristics, the combination of which has been developed to promote the maintenance of joint structures under normal conditions.
El ingrediente principal de la formulación es el Metilsulfonilmetano (MSM), un compuesto de azufre orgánico que participa en la síntesis de colágeno y otras proteínas estructurales del cartílago. El MSM interviene también en mecanismos celulares relacionados con la flexibilidad de las membranas, lo que resulta relevante en el contexto del mantenimiento de la movilidad articular. The main ingredient in the formulation is methylsulfonylmethane (MSM), an organic sulfur compound involved in the synthesis of collagen and other structural proteins of cartilage. MSM also plays a role in cellular mechanisms related to membrane flexibility, which is relevant in the context of maintaining joint mobility.
El segundo componente es omega-3. El omega-3 de origen vegetal, como el que proviene de algas, se encuentra en forma de fosfolípidos, lo que le otorga una mayor estabilidad oxidativa y, por ende, una biodisponibilidad superior en comparación con los omega-3 en forma de triglicéridos. The second component is omega-3. Plant-based omega-3, such as that derived from algae, is in the form of phospholipids, which gives it greater oxidative stability and, therefore, superior bioavailability compared to omega-3 in the form of triglycerides.
El omega 3 es un ácido graso esencial involucrado en funciones biológicas que contribuyen al equilibrio general del organismo, incluida la regulación de mecanismos asociados a la integridad celular. Asimismo, también promueve la estabilidad oxidativa, lo que prolonga la vida útil del producto. Omega-3 is an essential fatty acid involved in biological functions that contribute to the body's overall balance, including the regulation of mechanisms associated with cellular integrity. It also promotes oxidative stability, which extends the product's shelf life.
La combinación de MSM y Omega 3 crea un complemento alimenticio orientado al mantenimiento de las funciones articulares y del cartílago, dentro de los parámetros fisiológicos normales. The combination of MSM and Omega 3 creates a food supplement aimed at maintaining joint and cartilage functions within normal physiological parameters.
El complemento alimenticio de la presente invención está diseñado para ser administrado en forma de cápsulas, asegurando así una dosificación precisa y una protección óptima de los ingredientes activos frente a factores ambientales que podrían comprometer su eficacia, como la luz y la humedad. La formulación en cápsulas también facilita su consumo y almacenamiento, haciéndolo conveniente para los usuarios. Estas cápsulas están diseñadas para ser administradas oralmente, preferiblemente en una dosis diaria recomendada de dos cápsulas, que se consumirán antes de dormir. Esta pauta se ha definido considerando que, durante el descanso nocturno, el cuerpo humano activa procesos fisiológicos que pueden ser compatibles con el aprovechamiento óptimo de los nutrientes ingeridos. The dietary supplement of the present invention is designed to be administered in capsule form, thus ensuring precise dosage and optimal protection of the active ingredients from environmental factors that could compromise their efficacy, such as light and humidity. The capsule formulation also facilitates consumption and storage, making it convenient for users. These capsules are designed for oral administration, preferably at a recommended daily dose of two capsules, to be taken before bedtime. This guideline has been established considering that, during nighttime rest, the human body activates physiological processes that can be compatible with the optimal utilization of ingested nutrients.
Descripción de los Modos de Realización Preferente de la Invención Description of the Preferred Modes of Embodiment of the Invention
En una realización preferente de la invención, el complemento alimenticio se presenta en forma de cápsulas duras, cada una de las cuales contiene la siguiente formulación: In a preferred embodiment of the invention, the food supplement is presented in the form of hard capsules, each of which contains the following formulation:
• Metilsulfonilmetano (MSM) (400 mg) • Methylsulfonylmethane (MSM) (400 mg)
• Omega 3 (300 mg) • Omega 3 (300 mg)
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES202431641U ES1323788Y (en) | 2024-09-06 | 2024-09-06 | Dietary supplement to support joint function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES202431641U ES1323788Y (en) | 2024-09-06 | 2024-09-06 | Dietary supplement to support joint function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES1323788U true ES1323788U (en) | 2025-10-30 |
| ES1323788Y ES1323788Y (en) | 2026-01-23 |
Family
ID=97492495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES202431641U Active ES1323788Y (en) | 2024-09-06 | 2024-09-06 | Dietary supplement to support joint function |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES1323788Y (en) |
-
2024
- 2024-09-06 ES ES202431641U patent/ES1323788Y/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES1323788Y (en) | 2026-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101503970B1 (en) | Omega-3 enriched fish oil-in-water parenteral nutrition emulsions | |
| ES2256250T3 (en) | THERAPEUTIC COMBINATIONS OF FATTY ACIDS. | |
| US7713523B2 (en) | Solubilized CoQ-10 and carnitine | |
| US20060078625A1 (en) | Compositions including krill extracts and conjugated linoleic acid and methods of using same | |
| ES2695503B2 (en) | ENCAPSULATED FORMULATIONS | |
| ES2643843T3 (en) | Therapeutic application of krill oil parenterally | |
| CA2692394A1 (en) | Fatty acid compositions and methods of use | |
| BRPI0713642A2 (en) | anti-inflammatory composition, and use of a | |
| CA2567189A1 (en) | Treatment for asthma and arthritis and other inflammatory diseases | |
| JP2017526623A (en) | Mineral / amino acid complexes of active substances | |
| US20040265357A1 (en) | Combination of liponic acid and glutamine in food and pharmaceutical products | |
| ITMI20072051A1 (en) | PELLET BASED COMPOSITION OF LIPOIC ACID | |
| ES2956766T3 (en) | Tablets with a high content of active ingredients of omega-3 fatty acid salts and amino acids | |
| US20180055874A1 (en) | Fast acting joint relief formulations | |
| CA2461758A1 (en) | Use of cystathionine | |
| CA2613792A1 (en) | Methods and compositions for the prevention and treatment of inflammatory disease | |
| CN105901703A (en) | A marine organism type enteral nutrition preparation used for burn patients | |
| CA2567190C (en) | Combinations of hyaluronic acid and polyunsaturated fatty acids | |
| ES1323788U (en) | Dietary supplement to support joint function | |
| CN101888837B (en) | Composition of coenzyme Q10 and garlic oil to increase bioavailability of coenzyme Q-10 | |
| JP2009102235A (en) | Comprehensive nutritional composition | |
| BRPI0608512A2 (en) | vitamin blends | |
| ES2566948T3 (en) | Stable formulations of antiplatelet agents, omega-3 fatty acids and amylose in soft gelatin capsules | |
| ES2413497B1 (en) | Composition with high content in Omega 3, Omega 6 and Omega 9 | |
| PT2838529E (en) | COMPOSITION COMPOSING ALPHA-LIPIDIC ACID AND HONOKIOL FOR TREATING NEUROPATHIES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CA1K | Utility model application published |
Ref document number: 1323788 Country of ref document: ES Kind code of ref document: U Effective date: 20251030 |
|
| FG1K | Utility model granted |
Ref document number: 1323788 Country of ref document: ES Kind code of ref document: Y Effective date: 20260119 |